COVID-19, the role of immunomodulators (anakinra, sarilumab, siltuximab and tocilizumab) in…
Treatment of COVID-19 / immunomodulators such as anakinra, sarilumab, siltuximab and tocilizumab in the treatment of COVID-19: evidence of an over-activated immune response in the most severe form of COVID-19 is accumulating, with several…
